Detalles de la búsqueda
1.
Prevention of Hepatitis A Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2020.
MMWR Recomm Rep
; 69(5): 1-38, 2020 07 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32614811
2.
Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices.
MMWR Recomm Rep
; 67(1): 1-31, 2018 01 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29939980
3.
Notes from the field: reports of expired live attenuated influenza vaccine being administered--United States, 2007-2014.
MMWR Morb Mortal Wkly Rep
; 63(35): 773, 2014 Sep 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-25188496
4.
Postlicensure safety surveillance for high-dose trivalent inactivated influenza vaccine in the Vaccine Adverse Event Reporting System, 1 July 2010-31 December 2010.
Clin Infect Dis
; 54(11): 1608-14, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22441652
5.
Adverse event reports after tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines in pregnant women.
Am J Obstet Gynecol
; 207(1): 59.e1-7, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22727350
6.
Adverse events in pregnant women following administration of trivalent inactivated influenza vaccine and live attenuated influenza vaccine in the Vaccine Adverse Event Reporting System, 1990-2009.
Am J Obstet Gynecol
; 204(2): 146.e1-7, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-20965490
7.
Adverse events following administration to pregnant women of influenza A (H1N1) 2009 monovalent vaccine reported to the Vaccine Adverse Event Reporting System.
Am J Obstet Gynecol
; 205(5): 473.e1-9, 2011 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-21861964
8.
Safety profile of rotavirus vaccines among individuals agedâ¯≥8â¯months of age, United States, vaccine adverse event reporting system (VAERS), 2006-2019.
Vaccine
; 39(4): 746-750, 2021 01 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-33267969
9.
Safety review of tetanus toxoid, reduced diphtheria toxoid, acellular pertussis vaccines (Tdap) in adults aged ≥65â¯years, Vaccine Adverse Event reporting System (VAERS), United States, September 2010-December 2018.
Vaccine
; 38(6): 1476-1480, 2020 02 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31883809
10.
Erythema multiforme, Stevens Johnson syndrome, and toxic epidermal necrolysis reported after vaccination, 1999-2017.
Vaccine
; 38(7): 1746-1752, 2020 02 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31870573
11.
Vaccines and Guillain-Barré syndrome.
Drug Saf
; 32(4): 309-23, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19388722
12.
Death and serious illness following influenza vaccination: a multidisciplinary investigation.
Pharmacoepidemiol Drug Saf
; 18(6): 504-11, 2009 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-19373848
13.
Challenges in evaluating post-licensure vaccine safety: observations from the Centers for Disease Control and Prevention.
Expert Rev Vaccines
; 18(10): 1091-1101, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31580725
14.
Post-licensure surveillance of trivalent adjuvanted influenza vaccine (aIIV3; Fluad), Vaccine Adverse Event Reporting System (VAERS), United States, July 2016-June 2018.
Vaccine
; 37(11): 1516-1520, 2019 03 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30739795
15.
Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007.
MMWR Recomm Rep
; 56(RR-6): 1-54, 2007 Jul 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-17625497
16.
Reports of lower respiratory tract infection following dose 1 of RotaTeq and Rotarix vaccines to the Vaccine Adverse Event Reporting System (VAERS), 2008-2016.
Hum Vaccin Immunother
; 14(11): 2755-2759, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29993327
17.
Safety of currently licensed hepatitis B surface antigen vaccines in the United States, Vaccine Adverse Event Reporting System (VAERS), 2005-2015.
Vaccine
; 36(4): 559-564, 2018 01 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-29241647
18.
Safety of Second-Dose Single-Antigen Varicella Vaccine.
Pediatrics
; 139(3)2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-28174201
19.
Surveillance systems and methods for monitoring the post-marketing safety of influenza vaccines at the Centers for Disease Control and Prevention.
Expert Opin Drug Saf
; 15(9): 1175-83, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27268157
20.
Post-licensure surveillance of quadrivalent inactivated influenza (IIV4) vaccine in the United States, Vaccine Adverse Event Reporting System (VAERS), July 1, 2013-May 31, 2015.
Vaccine
; 34(22): 2507-12, 2016 05 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27015735